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Introduction
Constipation, a complaint conceptually regarded as disordered
movement of stool through the large intestine, afflicts many peo-
ple in the Western countries [1, 2]. The first approach for the
treatment of constipation consists in lifestyle changes including
increased fibre (about 30 g/day), and water (about 2 l/day) intake
and physical exercise. If these measures are ineffective, laxative
therapy has to be considered. Among laxatives, anthranoids are
the oldest used drugs in clinical practice and as self-medication
[3]. Senna is the most known anthranoid laxative; it is obtained
from the dried leaves and pods of Cassia acutifolia Delile and
Cassia angustifolia Vahl (Caesalpinaceae family). Senna contains
sennosides that are not absorbed in the small intestinal tract; 
in the colon, sennosides are metabolized by the bacterial 
-glucosidase and reductase to the pharmacologically active com-
pound, rhein anthrone [4, 5]. Rhein anthrone is poorly absorbed 
and produces a laxative effect throughout two independent
mechanisms: (i ) changing of colonic motility leading to an accel-
erated large intestinal transit and (ii ) alterations in colonic
adsorption and secretion of water and electrolytes resulting in
fluid accumulation [6].
In the last years, there has been the concern that therapeutic or
chronic use of anthranoid laxatives can cause structural damage
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Abstract
In recent years, the use of anthraquinone laxatives, in particular senna, has been associated with damage to the intestinal epithelial layer
and an increased risk of developing colorectal cancer. In this study, we evaluated the cytotoxicity of rhein, the active metabolite of senna,
on human colon adenocarcinoma cells (Caco-2) and its effect on cell proliferation. Cytotoxicity studies were performed using 3-(4,5-
dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT), neutral red (NR) and trans-epithelial electrical resistance (TEER) assays
whereas 3H-thymidine incorporation and Western blot analysis were used to evaluate the effect of rhein on cell proliferation. Moreover,
for genoprotection studies Comet assay and oxidative biomarkers measurement (malondialdehyde and reactive oxygen species) were
used. Rhein (0.1–10 g/ml) had no significant cytotoxic effect on proliferating and differentiated Caco-2 cells. Rhein (0.1 and 1 g/ml)
significantly reduced cell proliferation as well as mitogen-activated protein (MAP) kinase activation; by contrast, at high concentration
(10 g/ml) rhein significantly increased cell proliferation and extracellular-signal-related kinase (ERK) phosphorylation. Moreover, rhein
(0.1–10 g/ml): (i) did not adversely affect the integrity of tight junctions and hence epithelial barrier function; (ii) did not induce DNA
damage, rather it was able to reduce H2O2-induced DNA damage and (iii) significantly inhibited the increase in malondialdehyde and
reactive oxygen species (ROS) levels induced by H2O2/Fe2. Rhein was devoid of cytotoxic and genotoxic effects in colon adenocarci-
noma cells. Moreover, at concentrations present in the colon after a human therapeutic dosage of senna, rhein inhibited cell prolifera-
tion via a mechanism that seems to involve directly the MAP kinase pathway. Finally, rhein prevents the DNA damage probably via an
anti-oxidant mechanism.
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to colonic tissue and induce colonic neuropathy and colorectal
cancer. However, human and animal data in this area are inconsistent.
Three clinical studies have evaluated the potential side effects of
long-term use of anthraquinone laxatives on colonic nerve tissue
[7–9]. One study found a direct association between stimulant 
laxative use and anatomic changes in the colon [7] while two clinical
trials did not support the hypothesis that anthraquinone containing
laxatives are able to provoke relevant degenerative changes in the
colonic nerve tissue [8, 9]. van Gorkom and colleagues reported three
clinical studies showing increased cell proliferation in colonic 
tissue of patients treated with a single high dose of sennosides
[10–12]. Most epidemiological studies failed to find any association
between anthranoid laxative use and colorectal cancer [13–17],
although a prospective study showed an increased cell prolifera-
tion (interpreted as higher risk for developing colorectal cancer) in
patients using anthranoid laxatives [18]. Finally, two single case
reports identified an increased cell proliferation in patients using
anthranoid laxatives [19, 20]. Similar conflicting data have been
reported on preclinical studies. As a consequence of these data in
1995, the German Federal Institute for Drugs and Medical Devices
revised the product information of all medicinal products contain-
ing anthranoids and in 1998 the Food and Drug Administration
(FDA) classified the stimulant laxatives (including senna) from
category I (generally recognized as safe and effective) to category
III (further testing is required). In 2002, the FDA re-classified
senna, but not aloe and cascara, to category I. Although there is
no conclusive clinical evidence that senna is dangerous, there are
still doubts and unresolved questions on the safety of this drug
and its components. On this basis, physicians often underuse
anthraquinones laxatives and are more willing to use far more
expensive drugs that have a much shorter track record concerning
potential long-term consequences to the constipated patient.
Therefore, the aim of this study was to investigate the potential
damaging effects of the active anthranoid metabolite of senna,
rhein, on a human colon adenocarcinoma cell line, Caco-2.
The cytotoxicity of rhein on proliferating and differentiating
cells has been evaluated as well as its effects on cell proliferation,
genotoxicity and epithelial integrity, all of which are thought to be
associated with colorectal carcinogenesis.
Materials and methods
Chemicals
The 4,5-Dihydroxyanthraquinone-2-carboxylic acid (rhein), deoxycolic acid
(DCA), 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT)
and 1,1,3,3-tetramethoxypropane (malonaldehyde bis dimethyl acetal], stan-
dard MDA) were purchased from Sigma Aldrich S.r.l. (Milan, Italy).
Monoclonal primary antibodies for phosphorylated extracellular-signal-
related kinase ERK1/2 (pERK1/2) and ERK2 were obtained from Santa Cruz
Biotechnology Inc. (CA, USA) while peroxidase-conjugated (HRP) anti-
mouse IgG antibody was obtained from Amersham Biosciences Inc. (GE
Healthcare, Milan, Italy). All reagents for Western blot analysis and cell cul-
ture were obtained from Sigma Aldrich S.r.l. (Milan, Italy), Bio-Rad
Laboratories (Segrate, Italy) and Microglass Heim S.r.l. (Naples, Italy).
Rhein was dissolved in dimethylsulphoxide (DMSO) to obtain a final con-
centration of 0.1% (v/v) in the culture medium. The concentration range for
rhein (0.1–10 g/ml) used in the study was selected on the basis that a
human therapeutic dosage (20–40 mg of dianthrones derivatives) or an
overdosage (80–100 mg) of senna generate rhein concentrations of approx-
imately 0.1–1 g/ml (0.35–3.5 M) or 10 g/ml (35 M), respectively [3].
Cell culture
Caco-2, A-431 cells (American Type Culture Collection, LGC Promochen,
Italy) and human fibroblasts were cultured in 75 cm2 polystyrene flasks
(Falcon, Microglass Heim, Naples, Italy) as monolayers in modified Eagle
medium (MEM) containing 10% foetal bovine serum (FBS), 100 Units/ml
penicillin, 100 g/ml streptomycin and 1% non-essential amino acids. Cells
were cultured at 37C in a humidified 5% CO2 and 95% filtered air and the cul-
ture medium was replaced every 2 days. After washing in phosphate buffered
saline (PBS), cells were trypsinized with 0.25% trypsin-EDTA at 37C for 
5 min., centrifuged at 1000  g for 3 min. and then re-suspended in the
appropriate medium. Cell viability was determined by trypan blue staining.
Cytotoxicity assay
MTT assay
The effect of rhein on cell survival was measured using the CellTiter 96®
proliferation assay (MTT assay) (Promega, Madison, WI, USA) [21]. Caco-2
cells (passage between 26 and 29) were seeded in 96-wells plates at a 
concentration of 3  104 cells/well. After 48 hrs of culturing, the medium
was removed and the cells were treated with rhein (0.1–10 g/ml) at 37C
for 24 hrs. Following treatment, cells were washed and fresh medium was
replaced. After 48 hrs of culturing at 37C, 15 l MTT dye solution were
added to each well for 4 hrs. Finally, 100 l of solubilization/stop solution
were added to dissolve the purple crystals; absorbency of formazan was
measured at a wavelength () of 570 nm using a multiwell reader
(Rainbow, SLT, Austria). Treatments were compared with a positive control,
deoxycolic acid (250 M). Experiments were repeated independently three
times. The results are expressed as percentage of cell viability.
Neutral red (NR) assay
The NR assay system, one of the most used and sensitive cytotoxicity test,
is a mean of measuring living cells via the uptake of the vital dye neutral
red. Viable cells will take up the dye by active transport and incorporate the
dye into lysosomes, whereas non-viable cells will not take up the dye. An
increase or decrease in the number of cells or their physiological state
results in a concomitant change in the amount of dye incorporated by the
cells in the culture [22]. Caco-2 cells (passage between 26 and 29) were
seeded in 96-wells plates at a concentration of 1104 cells/well. After 
48 hrs of culturing, the medium was removed and the cells were treated
with rhein (0.1–10 g/ml) at 37C for 24 hrs. Following treatment, cells
were washed and 200 l NR dye solution (50 g/ml in DMEM) were added
to each well for 3 hrs at 37C. After washing in PBS, 100 l of 1% acetic
acid were added and the absorbency was measured at a wavelength () of
532 nm using a multiwell reader (Perkin-Elmer Instruments Waltham, MA,
USA). Treatments were compared with a positive control, deoxycolic acid
(250 M). The results are expressed as percentage of cell viability.
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Trans-epithelial electrical resistance (TEER) assay
TEER was monitored as an indication of tight junction formation and
epithelial monolayer integrity as previously described [23]. Falcon®-
Transwell inserts (0.4 m pore size; BD Bioscience, Buccinasco, Italy)
were coated with 0.01% type I rat-tail collagen (Sigma) and left to dry
overnight under ultraviolet (UV) lights in 6-well plates. Caco-2 cells (pas-
sage between 57 and 63) were seeded into these inserts in 2.5 ml aliquots
at a concentration of 2.5  105 cells/ml. Culture medium (1.5 ml) was
added to the basolateral compartment of each well. The cells were grown
on these inserts and the medium was changed every 2 days. After 7 days
of culturing TEER, readings (expressed as cm2) were taken using an
EVOM epithelial voltohmmeter with chopstick electrodes (World Precision
Instruments Inc., Stevenage, UK). Readings were taken every 24 hrs until
they stabilized (at days 14–16). At this point the cells, maintained at 37C
in a humidified 5% CO2 and 95% filtered air, were deemed fully differenti-
ated. The culture medium was replaced every other day for 21 days. A final
TEER reading was taken immediately before adding rhein (0.1–10 g/ml)
and after 24 and 48 hrs. Treatments were compared with a positive con-
trol, deoxycholic acid (250 M). The results are expressed as percentage
change in TEER compared with the TEER value at the start of the experi-
ment (time 0). Three independent experiments were conducted.
Paracellular permeability assay
Caco-2 monolayers in 6-well plates were incubated with rhein (0.1–
10 g/ml) in presence of 10 M fluorescein (Sigma). Samples (200 l)
were removed from the apical compartment at the beginning of the exper-
iment (time 0) and from the basolateral compartment after 24 and 48 hrs.
The samples fluorescein content was measured using a microplate reader
(Tecan SPECTRA Rainbow, PAA Ltd, UK) (488 nm excitation and 510 nm
emission). The paracellular permeability represents the amount of fluores-
cein in the basolateral compartment expressed as percentage of the
amount added to the apical compartment at the start of the experiment, to
give a measure of the relative amount of fluorescein travelling through the
Caco-2 monolayer tight junctions (percentage of monolayer permeability).
Three independent experiments were conducted.
Proliferation assay
3H-Thymidine incorporation
Caco-2 cells (passage between 28 and 34) were seeded in 24-well plates
at a density of 1.0 104 in Dulbecco’s modified Eagle’s medium (DMEM)
supplemented with 10% FBS. After 48 hrs of incubation, cells were treated
with rhein (0.1–10 g/ml) in the presence of 3H-thymidine (1 Ci/well) for
24 hrs. Medium was removed by aspiration, and after washing in PBS,
cells were scraped in 1 M NaOH (100 l/well) and collected on glass fibre
filter mats using an LKB (Bromma, Sweden) automatic cell harvester prior
to liquid scintillation counting. The effect of rhein on cell proliferation was
expressed as count per minute/mg of protein (CPM/mg protein) of incor-
porating 3H-Thymidine cells. The treatments were carried out in triplicate
and three independent experiments were performed.
Preparation of cytosolic fractions and Western blot analysis
Caco-2 cytosolic extracts were prepared as previously described [24].
Briefly, after rhein (0.1–10 g/ml) incubation for 24 hrs, the medium was
removed and cells were washed with ice-cold PBS. The cells were collected
by scraping for 10 min. at 4C with lysis buffer (50 mM Tris-HCl pH 	 7.4,
0.25% sodium deoxycholate, 150 mM NaCl, 1 mM EGTA, 1 mM NaF, 1%
NP-40, 1mM PMSF, 1 mM Na3VO4 containing complete protease inhibitor
cocktail [Roche Diagnostics, Mannheim, Germany]). After centrifugation at
16,200  g for 15 min. at 4C, the supernatants were collected and protein
concentration was determined by Bio-Rad Protein Assay (Bio-Rad, Milan,
Italy). For Western blot analysis, lysate aliquots containing 70 g of pro-
teins were separated on a 12% SDS-polyacrylamide gel and transferred to
a nitrocellulose membrane (Protran®, Protran Nitrocellulose Transfer
Membrane Schleicher & Schuell Bioscience, Dassel, Germany) using a Bio-
Rad Transblot (350 mA, 3 hrs). Proteins were visualized on the filters by
reversible staining with Ponceau-S solution (Sigma) and de-stained in PBS
containing 0.1% Tween 20. Membranes were blocked at 4C in milk buffer
(5% non-fat dry milk in PBS/Tween 0.1%) and then incubated overnight at
4C with mouse monoclonal antibodies for pERK1/2 and ERK2 (Santa Cruz,
DBA S.r.l, Italy). The mouse monoclonal anti-pERK1/2 and anti-ERK2 were
used at 1:1000 dilution in milk buffer (5% non-fat dry milk in PBS/Tween
0.1%). Subsequently, the membranes were incubated for 1 hr at room tem-
perature with 1:2000-dilution of antimouse IgG-HRP-conjugated second-
ary antibody (Amersham Biosciences, UK). After washing in PBS/Tween
0.1%, the membranes were analysed by enhanced chemiluminescence’s
(ECL; Amersham Biosciences). The optical density of the bands on autora-
diographic films was determined by an image analysis system (GS 700
Imaging Densitometer, Bio-Rad) equipped with a software Molecular
Analyst (IBM, Milan, Italy). The effect of rhein on the mitogen-activated
protein (MAP) kinase activation was expressed as ratio of densitometric
analysis of pERK1/2/total ERK bands.
Genotoxicity assay
DNA damage was examined by single-cell gel electrophoresis (Comet assay)
[25]. Caco-2 cells (passage between 33 and 37) were seeded in 
25 cm2 polystyrene flasks (Falcon) and grown to ~70% confluence. Then,
cells were incubated with rhein (0.1–10 g/ml) for 24 hrs and subsequently
they were trypsinized to obtain a suspension of 1.5 105 cells/ml. Aliquots
of cell suspension were incubated with and without H2O2 challenge (75 M
for 5 min. on ice) and then centrifuged at 1000  g for 5 min. at 4C. The
supernatants were discarded and the pellets were mixed with 85 l of 0.85%
low melting point agarose in PBS. Cells were added to previously prepared
gels of 1% normal melting point agarose in PBS. The gels on frosted slides
were suspended in lysis solution (2.5 M NaCl, 100 mM Na2EDTA, 10 mM Tris
and 1% Triton X-100, pH 10) at 4C for 1 hr, and then electrophoresed in
buffer (300 mM NaOH, 1 mM Na2EDTA, pH
12) at 26 V, 300 mA for 20 min.
After electrophoresis, gels were immersed in 0.4 M Tris–HCl, pH 7.5 
(3  5 min. washes) to neutralize the alkaline pH, and stained with 20 l of
ethidium bromide (2 g/ml) before scoring. Images were analysed using a
fluorescence microscope (Nikon, Florence, Italy) interfaced with a computer.
DNA damage (percentage of tail DNA) was quantified using Komet 5.0 image
analysis software (Kinetic Imaging, Liverpool, UK). Positive (H2O2; 75
mol/L) and negative (PBS) controls were included for all experiments. The
mean percentage of  tail DNA was calculated from 100 cells per gel (each sam-
ple in triplicate) and the mean of each independent experiment (n 	 3) was
used in the statistical analysis.
Antioxidant assay
TBARs assay
Lipid peroxidation products from Caco-2 cells were measured by the 
thiobarbituric acid colorimetric assay [26]. The reaction of lipid peroxides
J. Cell. Mol. Med. Vol 14, No 7, 2010
(formed after the oxidative stress) and the thiobarbituric acid (TBA) leads
to the formation of malondialdehyde that can be measured by colorimetric
detection of the chromogen (pink colour complex). Briefly, Caco-2 cells
were seeded in 6-well plates at a density of 3.0  106 in DMEM supple-
mented with 10% FBS. After treatment with rhein (0.1–10 g/ml) for 
24 hrs, cells were washed with PBS and incubated with the Fenton’s
reagent (Fe2/H2O2 1 mM) for 3 hrs at 37 C. After incubation, cells were
washed and scraped in PBS. Cells were lysed by six cycles of freezing and
thawing in PBS and then centrifuged at 12,600  g for 10 min. at 4C. To
150 l of cellular lysate were added 300 l of 10% (w/v) trichloroacetic
acid (TCA) and, after centrifugation at 16,200  g for 10 min., 0.67% (w/v)
thiobarbituric acid was added and the mixture was heated at 80C for 
30 min. After cooling, malondialdehyde (MDA) production was recorded
(A490nm) in a Beckman DU-62 spectrophotometer  (Beckman, Milan, Italy)
and the results are presented as mol of MDA/mg of cell proteins deter-
mined by the Bio-Rad protein assay. A standard curve of MDA was used to
quantify the MDA levels formed during the experiments.
Intracellular reactive oxygen species (ROS) measurement
The generation of intracellular ROS was estimated using the fluorescence
probe 2’,7’-dichlorfluorescein-diacetate (H2DCF-DA) [27]. The H2DCF-DA
is able to diffuse passively into cells, where the acetate is cleaved by intra-
cellular esterases to the non-fluorescent H2DCF that thereby traps it within
the cell. In the presence of intracellular ROS, H2DCF is rapidly oxidized to
the highly fluorescent 2,7- dichlorofluorescein (DCF). The DCF fluores-
cence intensity is paralleled to the amount of ROS formed intracellularly.
For the experiments, cells were plated in 96 multi-well black plates
(Corning, USA) at the density of 1104 cells per well and led to the differ-
entiation. Confluent Caco-2 cell monolayers were incubated for 24 hrs at
37C with rhein (0.1–10 g/ml). After washing in PBS, cells were incu-
bated for 30 min. with 200 l of 100 M DCFH-DA in Hank’s balanced salt
solution (HBSS) containing 1% FBS. Finally, cells were rinsed and incu-
bated with the Fenton reagent (H2O2/Fe2 2 mM) for 3 hrs at 37C. The
DCF fluorescence intensity was detected using a fluorescent microplate
reader (Perkin-Elmer Instruments) at the excitation wavelength () of 485 nm
and the emission wavelength () of 538 nm. The ROS levels were
expressed as fluorescence intensity (picogreen).
Statistical analysis
Results are expressed as mean  S.E.M of n experiments. The analyses of
results were carried out using GraphPad Prism Software (GraphPad
Software, Inc. San Diego, CA, USA). Comparisons between two sets of
data were made by Student’s t-test for paired data. When multiple compar-
isons against a single control were made, one-way ANOVA was used, fol-
lowed by Turkey-Kramer multiple comparisons test. A P-value less than
0.05 was considered significant. For Comet assay the differences between
means were evaluated by ANOVA, followed by post hoc LSD.
Results
MTT and NR assay
In the MTT assay, rhein in the concentration range of 0.1–
10 g/ml had no significant cytotoxic effect on Caco-2 cells after
24 hrs exposure (control: 100  0.0; rhein 0.1 g/ml: 94.69 
3.45; rhein 1 g/ml: 95.47  2.49; rhein 10 g/ml: 93.70 
0.42). Deoxycholic acid (DCA, 250 M), a secondary bile acid
used as positive control, significantly (P  0.001) reduced the cell
viability in proliferating Caco-2 cells (control: 100  0.0 and DCA
250 M: 69.04  2.21). These data have been confirmed by the
NR assay (control: 100  0.0; rhein 0.1 g/ml: 102.5  2.02;
rhein 1 g/ml: 93.26  7.14; rhein 10 g/ml: 91.21  5.07; DCA
250 M: 50.5  0.32).
TEER and fluorescein assay
Figures 1 and 2 show the effect of rhein on Caco-2 epithelial
monolayer integrity. Differentiated Caco-2 cells exhibit different
phenotypes characteristic of villus tip cells or crypt base cells and
they are a well-known experimental model to examine the mainte-
nance of junctional integrity according to a procedure previously
described [28]. All tested rhein concentrations (0.1–10 g/ml)
had no significant adverse effects on the epithelial monolayer, as
indicated by TEER value measurement after 24 and 48 hrs of rhein
exposure (Fig. 1A). As expected, the incubation of differentiated
Caco-2 cells with DCA (250 M), resulted in a marked decrease in
TEER value (~30%; P  0.001), reflecting disruption of entero-
cytes tight junctions (Fig. 1). The absence of detrimental effects of
rhein on tight junction integrity as assessed by TEER, was con-
firmed by the fluorescein flow assay (Fig. 1B) where no increase
in fluorescein flow from the apical to the basolateral compartment
of the Caco-2 monolayer occurred.
3H-Thymidine incorporation
Thymidine is a precursor of DNA and it is incorporated into new
DNA in proliferating cells. For this reason, the 3H-Thymidine incor-
poration into DNA during 24 hrs has been measured as an indica-
tor of cell proliferation, and thereby DNA synthesis. Rhein, at the
concentrations of 0.1 and 1 g/ml, significantly (P  0.001)
reduced the 3H-Thymidine incorporation in proliferating Caco-2
cells (Fig. 2). By contrast, rhein at the higher concentration 
(10 g/ml) significantly (P  0.001) increased Caco-2 cells pro-
liferation (Fig. 2). Moreover, rhein, at all concentrations used
(0.1–10 g/ml) did not modify the 3H-Thymidine incorporation in
proliferating A-431 cells (control: 548.5  60.48 CPM/mg; rhein
0.1 g/ml: 541.3  56.26 CPM/mg; rhein 1 g/ml: 612.7  56.63
CPM/mg; rhein 10 g/ml: 596.2  76.49 CPM/mg) and human
fibroblasts (control: 684.0  10.0 CPM/mg; rhein 0.1 g/ml:
585.5  22.50 CPM/mg; rhein 1 g/ml: 644.5  29.50 CPM/mg;
rhein 10 g/ml: 670.0  12.0 CPM/mg).
Western blot analysis
The possible molecular mechanism of rhein on cell proliferation
was investigated by studying its effect on the MAP kinase (MAPK)
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signalling pathways. The MAPK pathway involves two closely
related kinases, known as ERK 1 (ERK1, p44) and 2 (ERK2, p42)
that come from dimerization of total cytosolic ERK. The modula-
tion in ERK1 and ERK2 phosphorylation after 24 hrs rhein expo-
sure was consistent with the observed effect of rhein on cell pro-
liferation. At concentrations of 0.1 and 1 g/ml, a significant (P 
0.001) reduction in the expression of phosphorylated ERK1
(pERK1) and ERK2 (pERK2) was observed (Fig. 3). By contrast,
rhein at the higher concentration (10 g/ml) significantly (P 
0.001) increased pERK1 and pERK2 expression, resulting in MAP
kinase activation (Fig. 3).
Genotoxicity assay
The comet assay is a sensitive and valid method to evaluate the
potential genotoxic effect of a substance. Rhein (0.1–10 g/ml)
alone did not significantly affect DNA damage after 24 hrs expo-
sure suggesting the absence of a genotoxic effect. Exposure of
Caco-2 cells to hydrogen peroxide (75 M) produced a significant
(P  0.001) increase in the percentage of DNA in the comet tail,
indicating an increase in single-strand breaks (Fig. 4). Pre-treat-
ment Caco-2 cells with rhein for 24 hrs reduced, in a concentra-
tion-dependent manner, the H2O2-induced DNA damage. The
decrease was significant (P  0.05) at a rhein concentration of 
10 g/ml (Fig. 4).
MDA and intracellular ROS measurement
Fenton’s reagent, hydrogen peroxide (1 mM) in the presence of
iron (II) ions (1 mM), induced an oxidative stress in Caco-2 cells
after 3 hrs exposure, resulting in malondialdehyde production 
(P  0.01) (Fig. 5). Pre-incubation of Caco-2 cells for 24 hrs with
high concentration of rhein (10 g/ml) significantly (P  0.001)
reduced the increase of H2O2/Fe2-induced malondialdehyde
cytosolic levels (Fig. 5). Rhein at the concentrations of 0.1 and 
1 g/ml was inactive.
The exposure of the Caco-2 cells to H2O2/Fe2 (2 mM) 
produced a significant (P  0.0001) increase in ROS formation
(Fig. 6). A pre-treatment for 24 hrs with rhein (10 g/ml) reduced
significantly (P  0.05) the ROS formation as measured by the
inhibition of DCF fluorescence intensity (Fig. 6). Consistent with
the results obtained in the MDA assay, rhein at the concentrations
of 0.1 and 1 g/ml was not active (Fig. 6).
Discussion
Gastrointestinal tract mucosa shows a rapid cell turnover rate
determined by cell proliferation and cell loss (apoptosis)
processes [29]. The integrity of the epithelial cell layer is main-
tained by intercellular junctional complexes composed of tight
Fig. 1 Trans-epithelial electrical resistance
(TEER) of polarized Caco-2 monolayer
exposed to rhein (0.1–10 g/ml) and
deoxycholic acid (DCA, 250 M) for 24
and 48 hrs (A). Effect of rhein (0.1–10
g/ml) and deoxycholic acid (DCA, 250
M) on the colonic monolayer permeabil-
ity after 24 and 48 hrs exposure (B). ***
P  0.001 versus control (Ctrl), n 	 3,
mean  S.E.M.
Fig. 2 Effect of rhein (0.1–10 g/ml) on Caco-2 cell proliferation after 24 hrs
of incubation. *** P  0.001 versus control (Ctrl), n 	 3, mean  S.E.M.
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junctions, adherent junctions and desmosomes. Tight junctions
are essential structures for the physiological functions of epithe-
lial and endothelial cells, and have been suggested to have both
barrier and defence functions, including the regulation of paracel-
lular pathways. Changes in epithelial cell turnover and alterations
of the epithelial monolayer permeability can occur during many
gastro-intestinal diseases such as colon cancer. In fact, colon can-
cer cells exhibit both abnormal cell turnover and impaired tight
junction morphology, leading to increase of paracellular perme-
ability [30]. Furthermore, in the latter phases of carcinogenesis,
the disruption of cell-cell junctions with concomitant changes in
the junctional proteins expression represents a hallmark of cancer
cell invasion and metastasis [31].
Fig. 3 pERK1 (A) and pERK2 (B) expres-
sion (MAP-kinase activation) in Caco-2
cells after 24 hrs of rhein (0.1–10 g/ml)
incubation. Insert: representative
Western blot analysis. *** P  0.001
versus control (Ctrl), n 	 3, mean 
S.E.M.
Fig. 4 Effect of rhein (0.1–10 g/ml) on Caco-2 cells exposed () or not
() to 75 M hydrogen peroxide (H2O2). Insert: representative comet
images of a control cell (a), a severally damaged cell (b) and a partially
genoprotected cell (c). # P  0.001 versus untreated cells; * P  0.05
versus H2O2 alone, n 	 4, mean  S.E.M.
Fig. 5 Effect of rhein (0.1–10 g/ml) on Fenton’s reagent (H2O2/Fe2
1 mM)-induced malondialdehyde (MDA) production after 24 hrs expo-
sure in 7 days differentiated Caco-2 cells. # P  0.01 versus control (Ctrl)
and *** P  0.001 versus H2O2/Fe2 alone, n 	 3, mean  S.E.M.
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In the last decade, the use of anthraquinone laxatives, in par-
ticular the use of senna, has been associated with a damage of the
intestinal epithelial layer and an increased risk to develop colorec-
tal cancer. In this paper, we have demonstrated that rhein, the
active metabolite of senna, does not trigger cytotoxic or genotoxic
effects in a human colon adenocarcinoma cell line; moreover,
rhein shows modulatory effects on cellular proliferation depending
on the concentration used and possesses anti-genotoxic activity.
Caco-2 cells, which undergo differentiation in culture, are
widely used as a model for colorectal cancer; particularly to
assess effects on epithelial function [32, 33], genotoxicity [34, 35]
and cell proliferation [36].
Although there are conflicting data, it has been suggested that
the mechanism of the laxative effect of anthranoids is strictly corre-
lated to cell damage. Anthranoids laxatives have been proposed to
increase: (i ) the number of macrophages in the connective tissue of
the colonic mucosa, (ii ) the intensity of lysosomal activity and (iii )
the number of lysosomes in macrophages, Schwann cells and neu-
rones of the sub-mucosal plexus of the colonic mucosa [37, 38]. In
addition, recently, it has been reported that rhein in Caco-2 cells pro-
duces changes of membrane fluidity either via a reduction of adeno-
sine-5’-triphosphate (ATP) production or via an intercalation into
cell membranes [39]. Using the MTT and NR assays, we demon-
strated that rhein did not affect the vitality of proliferating Caco-2
cells; moreover, TEER and the fluorescein flow assays showed that
rhein did not alter the integrity of membrane barrier function, thus
excluding cell damage in the mechanism of rhein laxative effect. Our
results are in disagreement with some previous studies; here, we
have used rhein concentrations (0.35 and 3.5 M) corresponding to
concentrations reached in the colonic lumen after therapeutic doses
of anthranoid laxatives. Previous studies have reported a cytotoxic-
ity effect of rhein on intestinal mucosal cells using very high con-
centrations (
50 M) [11, 40].
It is well known that colorectal cancer is promoted by an
uncontrolled proliferation of mucosa cells in the terminal portion
of intestine. Conflicting results have been reported on the effect of
rhein on cell proliferation. Two pre-clinical in vivo studies reported
no effect of rhein on intestinal cell proliferation [41, 42] whereas
other authors showed a stimulatory effect [40], and an inhibitory
effect [43]. In this paper, for the first time we report a modulatory
action of rhein on cell proliferation, depending on the concentra-
tion used. In fact, our experiments showed that rhein, at the con-
centrations of 0.1 and 1 g/ml (rhein concentrations present in
the colon after a human therapeutic dosage of senna) reduced the
cell proliferation of human colon adenocarcinoma cells; whereas,
rhein at the high concentration (10 g/ml, concentration corre-
sponding to rhein present in the colon after a dosage of senna ten-fold
higher then therapeutic dosage) produced a significant increase of
the human colon adenocarcinoma cell proliferation. Interestingly,
long-term in vivo studies have shown that senna, used at laxative
dosage, reduced the appearance of preneoplastic lesions and
tumours, whereas a diarrhogenic dose increases the appearance
of tumours induced by a carcinogenic agent [44, 45]. Whether or
not the effect of rhein is time dependent has been not determined
in this study. Also, it would be interesting to investigate in future
studies if the effect of rhein involves c-Jun N-terminal kinase
(JNK) or related pathways.
Using the normal human fibroblast cells and an epidermoid
carcinoma cell line from human skin (A-431), we have demon-
strated that the effect of rhein on cell proliferation is tumour  and
colon specific, respectively.
One of the most important pathway in cell proliferation is rep-
resented by the MAP kinases. MAPKs encompass a group of
enzymes recruited in response to cellular stress, including heat
and osmotic stress, cytokines and UV irradiation [46, 47]. The
accepted role of MAPKs is to produce cellular response to those
stresses by integrating multiple stimuli and activating transcrip-
tion factors. In most cell lines, MAPKs have been implicated in
regulating mitogenic responses and in the synthesis of stress
response proteins [42]. The three major MAPK families have been
recognized as p38 MAPK, ERK1 and ERK2 and stress-activated
protein kinase (SAPK/JNK). Although the molecular mechanisms
inducing MAPKs pathways activation are not totally clear, it is well
known that ERK1,2 phosphorylated proteins stimulate the cell
growth and inhibit the apoptotic processes [48,  49]. In this study,
we observed that rhein at concentrations of 0.1 and 1 g/ml
reduced ERK1 and ERK2 phosphorylated proteins expression. By
contrast, rhein at the concentration of 10 g/ml determined an
increase of ERK1 and ERK2 activation. These findings suggest that
rhein modulates cell proliferation via an involvement of the MAPK
pathway either inhibiting or stimulating the phosphorylation of
ERK proteins. Our results are consistent with a recent study show-
ing that rhein modulates cell proliferation of articular chondrocytes
by acting on ERK and JNK-AP-1-dependent pathways [50].
Interestingly, other compounds isolated from wild plants, such as
Saxifraga stolonifera and rhubarb have been reported to inhibit the
proliferation of cancer cells by apoptosis induction or ERK phos-
phorylation inhibition [51, 52].
Studies in human beings and animals implicate oxidative DNA
damage as an important factor in mutagenis and carcinogenesis
Fig. 6 Effect of rhein (0.1–10 g/ml) on Fenton’s reagent (H2O2/Fe2
2 mM)-induced reactive species reagents production after 24 hrs expo-
sure in differentiated Caco-2 cells. # P  0.001 versus control (Ctrl) and
* P  0.05 versus H2O2/Fe2 alone, n 	 3, mean  S.E.M.
J. Cell. Mol. Med. Vol 14, No 7, 2010
[53–55]. In our experiments, rhein did not induce DNA damage in
Caco-2 cells suggesting that it is not a genotoxic agent. In fact,
rhein exerted a protective effect on hydrogen peroxide-induced
DNA damage in human colon carcinoma cells at the concentration
of 10 g/ml. This is consistent with a previous report showing a
rhein-mediated inhibition of DNA damage induced by Trp-P-1 in
human lymphocytes [56].
In order to investigate the mechanism responsible for the
genoprotective effect of rhein on H2O2-induced DNA damage, we
investigated MDA and ROS cytosolic levels in Caco-2 cells. In
accordance with other papers, exposure of Caco-2 cells to
hydrogen peroxide and ferrous sulphate (Fe2) resulted in
oxidative damage, assessed as increased cytosolic levels of MDA
and ROS [57, 58]. Pre-treatment with rhein significantly reduced
the Fenton reaction-induced MDA and ROS formation, suggest-
ing a potential antioxidant mechanism in the anti-genotoxic
effects of rhein.
In conclusion, this paper provides in vitro evidence that rhein,
the active metabolite of senna, does not possess cancer-inducing
potential at concentrations corresponding to human therapeutic
doses of senna. At such concentrations, rhein was not cytotoxic in
both proliferating and differentiated cells, did not disrupt tight
junctions and in fact inhibited colon adenocarcinoma cell prolifer-
ation. Such results indicate a lack of tumour-promoting activity.
The molecular mechanism of the rhein anti-proliferative effect
seems to involve directly the MAP kinase pathway. Furthermore,
genotoxicity studies have shown that rhein did not induce DNA
damage; by contrast, it was able to protect the DNA against the
genotoxic action of hydrogen peroxide, probably because of an
anti-oxidant action.
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